Montclair Radiology Using AI to Detect Lung Cancer

Jersey City NJ

21 July, 2021

9:29 PM

Description

Montclair, NJ: Montclair Radiology announced today they have partnered with MeVis, a leading medical imaging software company, to harness the power of artificial intelligence to help detect early lung cancer on CT scans. Veolity LungCAD software, developed by MeVis, is approved by the FDA to detect nodules in the lung that may represent early lung cancer. “Lung cancer is one of the most common cancers worldwide and causes the most cancer deaths each year. Over 2 million new cases occurred in 2020 with a mortality of 1.8 million people. At Montclair Radiology we have been leaders in CT lung cancer screening for many years. The addition of Veolity LungCAD to our protocol will help us detect lung cancer early and save lives,” says Michael Pollack, MD, President at Montclair Radiology. Features and benefits include: Automatically detects lung nodulesAutomatically provides lung nodule measurementsAllows for easy comparison between studies. Veolity LungCAD was implemented on July 15th, on all lung CT scans performed at all Montclair Radiology locations at no additional cost to patients. To schedule an appointment at Montclair Radiology, visit Montclairradiology.com. About Montclair Radiology: Montclair Radiology is the leading provider of outpatient imaging in northern New Jersey. Accredited and designated as a Lung Cancer Screening Center by the American College of Radiology and the only practice in Essex County to earn both Diagnostic Imaging Center of Excellence and the Breast Imaging Center of Excellence accreditations by the ACR. They have been serving the community for over 75 years and offer 5 convenient locations with innovative diagnostic imaging technology along with caring team members.